Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Are next-generation sequencing results knocking on Heaven's door for transplantation planning in chronic myelomonocytic leukemia?

Sanz GF, Ibañez M, Mora E.

Haematologica. 2020 Mar;105(3):530-533. doi: 10.3324/haematol.2019.240853. No abstract available.

2.

Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7.

Crisà E, Kulasekararaj AG, Adema V, Such E, Schanz J, Haase D, Shirneshan K, Best S, Mian SA, Kizilors A, Cervera J, Lea N, Ferrero D, Germing U, Hildebrandt B, Martínez ABV, Santini V, Sanz GF, Solé F, Mufti GJ.

Leukemia. 2020 Feb 17. doi: 10.1038/s41375-020-0728-x. [Epub ahead of print]

PMID:
32066866
3.

In MDS, is higher risk higher reward?

Sanz GF.

Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):381-390. doi: 10.1182/hematology.2019000042.

PMID:
31808894
4.

Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet.

Itzykson R, Fenaux P, Bowen D, Cross NCP, Cortes J, De Witte T, Germing U, Onida F, Padron E, Platzbecker U, Santini V, Sanz GF, Solary E, Van de Loosdrecht A, Malcovati L.

Hemasphere. 2018 Nov 29;2(6):e150. doi: 10.1097/HS9.0000000000000150. eCollection 2018 Dec.

5.

Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?

Sanz GF, Ibañez M, Such E.

Blood Adv. 2019 Nov 12;3(21):3454-3460. doi: 10.1182/bloodadvances.2019000680.

6.

Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.

Sanz J, Montoro J, Solano C, Valcárcel D, Sampol A, Ferrá C, Parody R, Lorenzo I, Montesinos P, Ortí G, Hernández-Boluda JC, Balaguer-Roselló A, Guerreiro M, Carretero C, Sanz GF, Sanz MA, Piñana JL.

Biol Blood Marrow Transplant. 2020 Feb;26(2):358-366. doi: 10.1016/j.bbmt.2019.10.014. Epub 2019 Oct 23.

PMID:
31655119
7.

Transfusion management in multiple myeloma patients receiving daratumumab: Experience of a single tertiary care centre.

Solves P, Tur S, Arnao M, Freiria C, Dominguez L, Pons MJ, Gómez I, Sanz GF, Carpio N.

Transfus Apher Sci. 2019 Oct 4:102658. doi: 10.1016/j.transci.2019.09.011. [Epub ahead of print] No abstract available.

PMID:
31607551
8.

Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic Anemia.

Sanz J, Moscardó F, Montoro J, Cano I, Guerreiro M, Dasí MA, Solves P, Lorenzo I, Gómez-Segui I, Montesinos P, Mora E, Arnao M, Sempere A, Jarque I, Carretero C, Senent L, Vicente A, Andreu R, Luna I, Balaguer-Roselló A, Carpio N, Sanz GF, Sanz MA, Piñana JL.

Biol Blood Marrow Transplant. 2020 Jan;26(1):83-87. doi: 10.1016/j.bbmt.2019.08.020. Epub 2019 Sep 4.

PMID:
31493538
9.

Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.

Rodríguez-Veiga R, Montesinos P, Boluda B, Lorenzo I, Martínez-Cuadrón D, Salavert M, Pemán J, Calvillo P, Cano I, Acuña E, Villalba A, Piñana JL, Sanz J, Solves P, Senent L, Vicente A, Sempere A, Cervera J, Barragán E, Jarque I, Torres A, Sanz MA, Sanz GF.

Ann Hematol. 2019 Sep;98(9):2081-2088. doi: 10.1007/s00277-019-03744-5. Epub 2019 Jun 25.

PMID:
31240471
10.

Comparison of transfusion requirements in adult patients undergoing Haploidentical or single-unit umbilical cord blood stem cell transplantation.

Solves P, Sanz J, Gómez I, de la Puerta R, Arnao M, Montoro J, Piñana JL, Carretero C, Balaguer A, Guerreiro M, Andreu R, Rodríguez R, Montesinos P, Jarque I, Lorenzo JI, Carpio N, Sanz MÁ, Sanz GF.

Eur J Haematol. 2019 Sep;103(3):172-177. doi: 10.1111/ejh.13270. Epub 2019 Jul 3.

PMID:
31177565
11.

Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients.

Rodríguez-Veiga R, Montesinos P, García E, Boluda B, Rojas R, Serrano J, Martínez-Cuadrón D, Martín C, Sanz J, Tabares S, Piñana JL, Lorenzo I, Montoro J, Salavert M, Pemán J, Jarque I, Solves P, Sanz GF, Torres A, Sanz MA.

Mycoses. 2019 May;62(5):418-427. doi: 10.1111/myc.12891. Epub 2019 Mar 8.

PMID:
30633829
12.

Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimen.

Montoro J, Sanz J, Lorenzo JI, Montesinos P, Rodríguez-Veiga R, Salavert M, González E, Guerreiro M, Carretero C, Balaguer A, Gómez I, Solves P, Sanz GF, Sanz MA, Piñana JL.

Eur J Haematol. 2019 Apr;102(4):331-340. doi: 10.1111/ejh.13202. Epub 2019 Feb 12.

PMID:
30506598
13.

Current management of patients with chronic myelomonocytic leukemia.

Mora E, Sanz GF.

Curr Opin Oncol. 2018 Nov;30(6):409-417. doi: 10.1097/CCO.0000000000000486. Review.

PMID:
30169461
14.

Single umbilical cord blood with or without CD34+ cells from a third-party donor in adults with leukemia.

Sanz J, Kwon M, Bautista G, Sanz MA, Balsalobre P, Piñana JL, Solano C, Duarte R, Ferrá C, Lorenzo I, Martín C, Barba P, Pascual MJ, Martino R, Gayoso J, Buño I, Regidor C, de la Iglesia A, Montoro J, Díez-Martín JL, Sanz GF, Cabrera R.

Blood Adv. 2017 Jun 20;1(15):1047-1055. doi: 10.1182/bloodadvances.2017006999. eCollection 2017 Jun 27.

15.

Allogeneic hematopoietic cell transplantation in an adult patient with Glanzmann thrombasthenia.

Cid AR, Montesinos P, Sánchez-Guiu I, Haya S, Lorenzo JI, Sanz J, Moscardo F, Puig N, Planelles D, Bonanad S, Sanz GF, Vicente V, González-Manchón C, Lozano ML, Rivera J, Sanz MA.

Clin Case Rep. 2017 Oct 5;5(11):1887-1890. doi: 10.1002/ccr3.1206. eCollection 2017 Nov.

16.

Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation.

Solves P, Sanz J, Freiria C, Santiago M, Villalba A, Gómez I, Montesinos P, Montoro J, Piñana JL, Lorenzo JI, Puig N, Sanz GF, Sanz MÁ, Carpio N.

Ann Hematol. 2018 Jan;97(1):161-167. doi: 10.1007/s00277-017-3168-6. Epub 2017 Nov 17.

PMID:
29150812
17.

Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.

Ramos F, Robledo C, Pereira A, Pedro C, Benito R, de Paz R, Del Rey M, Insunza A, Tormo M, Díez-Campelo M, Xicoy B, Salido E, Sánchez-Del-Real J, Arenillas L, Florensa L, Luño E, Del Cañizo C, Sanz GF, María Hernández-Rivas J; Spanish Group for Myelodysplastic Syndromes (GESMD).

Am J Hematol. 2017 Sep;92(9):E534-E541. doi: 10.1002/ajh.24813. Epub 2017 Jul 19.

18.

Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).

Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, Pedro C, Tormo M, Montoro J, Díez-Campelo M, Blanco ML, Arrizabalaga B, Xicoy B, Bonanad S, Jerez A, Nomdedeu M, Ferrer A, Sanz GF, Florensa L.

Am J Hematol. 2017 Jul;92(7):614-621. doi: 10.1002/ajh.24732. Epub 2017 May 9.

19.

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.

Park S, Hamel JF, Toma A, Kelaidi C, Thépot S, Campelo MD, Santini V, Sekeres MA, Balleari E, Kaivers J, Sapena R, Götze K, Müller-Thomas C, Beyne-Rauzy O, Stamatoullas A, Kotsianidis I, Komrokji R, Steensma DP, Fensterl J, Roboz GJ, Bernal T, Ramos F, Calabuig M, Guerci-Bresler A, Bordessoule D, Cony-Makhoul P, Cheze S, Wattel E, Rose C, Vey N, Gioia D, Ferrero D, Gaidano G, Cametti G, Pane F, Sanna A, Germing U, Sanz GF, Dreyfus F, Fenaux P.

J Clin Oncol. 2017 May 10;35(14):1591-1597. doi: 10.1200/JCO.2016.71.3271. Epub 2017 Mar 28.

PMID:
28350519
20.

A Lot to Learn about Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia.

Sanz GF.

Biol Blood Marrow Transplant. 2017 May;23(5):713-714. doi: 10.1016/j.bbmt.2017.03.011. Epub 2017 Mar 9. No abstract available.

21.

Reply to M.A. Lichtman.

Arenillas L, Calvo X, Sanz GF, Florensa L.

J Clin Oncol. 2017 Apr 20;35(12):1376-1377. doi: 10.1200/JCO.2016.71.3941. Epub 2017 Jan 30. No abstract available.

PMID:
28135144
22.

Isohaemagglutinin production after minor ABO incompatible umbilical cord blood transplantation.

Solves P, Saus A, Osorio J, Gómez-Seguí I, Carpio N, Sanz GF, Sanz MÁ.

Transfus Med. 2017 Apr;27(2):147-149. doi: 10.1111/tme.12386. Epub 2017 Jan 22. No abstract available.

PMID:
28111815
23.

ABO incompatibility does not influence transfusion requirements in patients undergoing single-unit umbilical cord blood transplantation.

Solves P, Carpio N, Carretero C, Lorenzo JI, Sanz J, Gómez I, López-Chuliá F, Arilla MJ, Regadera AI, Montesinos P, Sanz GF, Sanz MÁ.

Bone Marrow Transplant. 2017 Mar;52(3):394-399. doi: 10.1038/bmt.2016.264. Epub 2016 Oct 31.

PMID:
27797368
24.

Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.

Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, Ardanaz MT, Pedro C, Tormo M, Montoro J, Díez-Campelo M, Arrizabalaga B, Xicoy B, Bonanad S, Jerez A, Nomdedeu B, Ferrer A, Sanz GF, Florensa L.

Mod Pathol. 2016 Dec;29(12):1541-1551. doi: 10.1038/modpathol.2016.146. Epub 2016 Aug 26.

25.

Advances in haploidentical stem cell transplantation for hematologic malignancies.

Montoro J, Sanz J, Sanz GF, Sanz MA.

Leuk Lymphoma. 2016 Aug;57(8):1766-75. doi: 10.3109/10428194.2016.1167204. Epub 2016 Apr 13. Review.

PMID:
27424663
26.

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.

Elena C, Gallì A, Such E, Meggendorfer M, Germing U, Rizzo E, Cervera J, Molteni E, Fasan A, Schuler E, Ambaglio I, Lopez-Pavia M, Zibellini S, Kuendgen A, Travaglino E, Sancho-Tello R, Catricalà S, Vicente AI, Haferlach T, Haferlach C, Sanz GF, Malcovati L, Cazzola M.

Blood. 2016 Sep 8;128(10):1408-17. doi: 10.1182/blood-2016-05-714030. Epub 2016 Jul 6.

27.

Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.

Arenillas L, Calvo X, Luño E, Senent L, Alonso E, Ramos F, Ardanaz MT, Pedro C, Tormo M, Marco V, Montoro J, Díez-Campelo M, Brunet S, Arrizabalaga B, Xicoy B, Andreu R, Bonanad S, Jerez A, Nomdedeu B, Ferrer A, Sanz GF, Florensa L.

J Clin Oncol. 2016 Sep 20;34(27):3284-92. doi: 10.1200/JCO.2016.66.9705. Epub 2016 Jul 5.

PMID:
27382099
28.

Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.

Ramos F, Robledo C, Izquierdo-García FM, Suárez-Vilela D, Benito R, Fuertes M, Insunza A, Barragán E, Del Rey M, García-Ruiz de Morales JM, Tormo M, Salido E, Zamora L, Pedro C, Sánchez-Del-Real J, Díez-Campelo M, Del Cañizo C, Sanz GF, Hernández-Rivas JM; Spanish Group for Myelodysplastic Syndromes (GESMD).

Oncotarget. 2016 May 24;7(21):30492-503. doi: 10.18632/oncotarget.9026.

29.

Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia.

Rocha V, Ruggeri A, Spellman S, Wang T, Sobecks R, Locatelli F, Askar M, Michel G, Arcese W, Iori AP, Purtill D, Danby R, Sanz GF, Gluckman E, Eapen M; Eurocord, Cord Blood Committee Cellular Therapy Immunobiology Working Party of the European Group for Blood and Marrow Transplantation, Netcord, and the Center for International Blood and Marrow Transplant Research.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1284-1289. doi: 10.1016/j.bbmt.2016.04.007. Epub 2016 Apr 16.

30.

Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.

Montesinos P, Rodríguez-Veiga R, Boluda B, Martínez-Cuadrón D, Cano I, Lancharro A, Sanz J, Arilla MJ, López-Chuliá F, Navarro I, Lorenzo I, Salavert M, Pemán J, Calvillo P, Martínez J, Carpio N, Jarque I, Sanz GF, Sanz MA.

Bone Marrow Transplant. 2015 Nov;50(11):1465-72. doi: 10.1038/bmt.2015.181. Epub 2015 Aug 17.

PMID:
26281032
31.

Risk of Rh (D) alloimmunisation after Rh (D) positive platelet transfusions in patients undergoing haematopoietic stem cell transplantation.

Solves P, Carpio N, Gómez I, Hernani R, Sanz GF, Sanz MA.

Transfus Med. 2015 Feb;25(1):49-50. doi: 10.1111/tme.12179. Epub 2015 Mar 4. No abstract available.

PMID:
25737308
32.

One-unit versus two-unit cord-blood transplantation.

Sanz J, Sanz GF, Sanz MA.

N Engl J Med. 2015 Jan 15;372(3):287-8. doi: 10.1056/NEJMc1414419. No abstract available.

PMID:
25587955
33.

Bloodstream infections in adult patients undergoing cord blood transplantation from unrelated donors after myeloablative conditioning regimen.

Sanz J, Cano I, González-Barberá EM, Arango M, Reyes J, Montesinos P, Lorenzo I, Jarque I, Martínez J, López F, Arilla MJ, Lancharro A, Moscardó F, López-Hontangas JL, Salavert M, Sanz MA, Sanz GF.

Biol Blood Marrow Transplant. 2015 Apr;21(4):755-60. doi: 10.1016/j.bbmt.2014.12.038. Epub 2015 Jan 10.

34.

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Fenaux P, Haase D, Sanz GF, Santini V, Buske C; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii57-69. doi: 10.1093/annonc/mdu180. Epub 2014 Jul 25. No abstract available.

35.

Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q).

Sekeres MA, Swern AS, Fenaux P, Greenberg PL, Sanz GF, Bennett JM, Dreyfus F, List AF, Li JS, Sugrue MM.

Blood Cancer J. 2014 Aug 29;4:e242. doi: 10.1038/bcj.2014.62. No abstract available.

36.

Effect of CD8⁺ cell content on umbilical cord blood transplantation in adults with hematological malignancies.

Moscardó F, Sanz J, Carbonell F, Sanz MA, Larrea L, Montesinos P, Lorenzo I, Vera B, Boluda B, Salazar C, Cañigral C, Planelles D, Jarque I, Solves P, Martín G, López F, de la Rubia J, Martínez J, Carpio N, Martínez-Cuadrón D, Puig N, Montoro JA, Roig R, Sanz GF.

Biol Blood Marrow Transplant. 2014 Nov;20(11):1744-50. doi: 10.1016/j.bbmt.2014.06.038. Epub 2014 Jul 5.

37.

Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience.

Sanz J, Arango M, Carpio N, Montesinos P, Moscardó F, Martín G, López F, Jarque I, Lorenzo I, de la Rubia J, Solves P, Boluda B, Salazar C, Cañigral C, Sanz MA, Sanz GF.

Bone Marrow Transplant. 2014 Aug;49(8):1084-8. doi: 10.1038/bmt.2014.107. Epub 2014 Jun 2.

PMID:
24887383
38.

Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion.

Sánchez-García J, Del Cañizo C, Lorenzo I, Nomdedeu B, Luño E, de Paz R, Xicoy B, Valcárcel D, Brunet S, Marco-Betes V, García-Pintos M, Osorio S, Tormo M, Bailén A, Cerveró C, Ramos F, Diez-Campelo M, Such E, Arrizabalaga B, Azaceta G, Bargay J, Arilla MJ, Falantes J, Serrano-López J, Sanz GF; Spanish Group on Myelodysplastic Syndromes (GES MD).

Br J Haematol. 2014 Jul;166(2):189-201. doi: 10.1111/bjh.12876. Epub 2014 Apr 10.

PMID:
24716538
39.

T cell-depleted related HLA-mismatched peripheral blood stem cell transplantation as salvage therapy for graft failure after single unit unrelated donor umbilical cord blood transplantation.

Moscardó F, Romero S, Sanz J, Sanz MA, Montesinos P, Lorenzo I, Solves P, Carpio N, Sanz GF.

Biol Blood Marrow Transplant. 2014 Jul;20(7):1060-3. doi: 10.1016/j.bbmt.2014.03.024. Epub 2014 Mar 28.

40.

Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation.

Sanz J, Jaramillo FJ, Planelles D, Montesinos P, Lorenzo I, Moscardó F, Martin G, López F, Martínez J, Jarque I, de la Rubia J, Larrea L, Sanz MA, Sanz GF.

Biol Blood Marrow Transplant. 2014 Jan;20(1):106-10.

PMID:
24516896
41.

EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases.

Sanz J, Arango M, Senent L, Jarque I, Montesinos P, Sempere A, Lorenzo I, Martín G, Moscardó F, Mayordomo E, Salavert M, Cañigral C, Boluda B, Salazar C, López-Hontangas JL, Sanz MA, Sanz GF.

Bone Marrow Transplant. 2014 Mar;49(3):397-402. doi: 10.1038/bmt.2013.190. Epub 2013 Dec 2.

PMID:
24292521
42.

Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.

Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, Arcese W, Barker JN, Baxter-Lowe LA, Brown M, Fernandez-Vina MA, Freeman J, He W, Iori AP, Horowitz MM, Locatelli F, Marino S, Maiers M, Michel G, Sanz GF, Gluckman E, Rocha V; Center for International Blood and Marrow Transplant Research, Netcord, Eurocord, and the European Group for Blood and Marrow Transplantation.

Blood. 2014 Jan 2;123(1):133-40. doi: 10.1182/blood-2013-05-506253. Epub 2013 Oct 18.

43.

Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.

Arenillas L, Mallo M, Ramos F, Guinta K, Barragán E, Lumbreras E, Larráyoz MJ, De Paz R, Tormo M, Abáigar M, Pedro C, Cervera J, Such E, José Calasanz M, Díez-Campelo M, Sanz GF, Hernández JM, Luño E, Saumell S, Maciejewski J, Florensa L, Solé F.

Genes Chromosomes Cancer. 2013 Dec;52(12):1167-77. doi: 10.1002/gcc.22112. Epub 2013 Oct 7.

PMID:
24123380
44.

Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms.

Sanz J, Wagner JE, Sanz MA, DeFor T, Montesinos P, Bachanova V, Lorenzo I, Warlick E, Sanz GF, Brunstein C.

Biol Blood Marrow Transplant. 2013 Dec;19(12):1725-30. doi: 10.1016/j.bbmt.2013.09.015. Epub 2013 Sep 30.

45.

Sequencing of a novel HLA-B allele, B*51:153, in a Spanish individual.

Planelles D, Balas A, Sanz GF, Rodríguez-Cebriá M, Vicario JL.

Tissue Antigens. 2013 Oct;82(4):297. doi: 10.1111/tan.12195. Epub 2013 Aug 23.

PMID:
24033231
46.

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.

Malcovati L, Hellström-Lindberg E, Bowen D, Adès L, Cermak J, Del Cañizo C, Della Porta MG, Fenaux P, Gattermann N, Germing U, Jansen JH, Mittelman M, Mufti G, Platzbecker U, Sanz GF, Selleslag D, Skov-Holm M, Stauder R, Symeonidis A, van de Loosdrecht AA, de Witte T, Cazzola M; European Leukemia Net.

Blood. 2013 Oct 24;122(17):2943-64. doi: 10.1182/blood-2013-03-492884. Epub 2013 Aug 26.

47.

Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation.

Sanz J, Picardi A, Hernández Boluda JC, Martín C, Ferrá C, Nozzoli C, Gonzalez-Vicent M, Rambaldi A, Valcarcel D, Verdeguer A, Serrano D, de Heredia CD, Pascual MJ, de Paz R, Montesinos P, Bartolozzi B, Algarotti A, Sanz MA, Arcese W, Sanz GF; GETH and GITMO.

Biol Blood Marrow Transplant. 2013 Sep;19(9):1387-92. doi: 10.1016/j.bbmt.2013.07.004. Epub 2013 Jul 11.

48.

Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes.

Saumell S, Florensa L, Luño E, Sanzo C, Cañizo C, Hernández JM, Cervera J, Gallart MA, Carbonell F, Collado R, Arenillas L, Pedro C, Bargay J, Nomdedeu B, Xicoy B, Vallespí T, Raya JM, Belloch L, Sanz GF, Solé F.

Br J Haematol. 2012 Nov;159(3):311-21. doi: 10.1111/bjh.12035. Epub 2012 Sep 7.

PMID:
22958186
49.

Screening for IDH mutations in chronic myelomonocytic leukemia.

Ibañez M, Such E, Cervera J, Luna I, Gómez-Seguí I, López-Pavía M, Avaria A, Senent ML, Sanz GF, Sanz MA.

Leuk Lymphoma. 2013 Feb;54(2):406-7. doi: 10.3109/10428194.2012.701295. Epub 2012 Oct 16. No abstract available.

PMID:
22906102
50.

Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival.

Santamaría C, Ramos F, Puig N, Barragán E, de Paz R, Pedro C, Insunza A, Tormo M, Del Cañizo C, Diez-Campelo M, Xicoy B, Salido E, Sánchez del Real J, Hernández M, Chillón C, Sanz GF, García-Sanz R, San Miguel JF, González M.

Ann Hematol. 2012 Dec;91(12):1887-95. doi: 10.1007/s00277-012-1538-7. Epub 2012 Aug 9.

PMID:
22875062

Supplemental Content

Support Center